Increased prevalence of APC resistance (Factor V Leiden mutation) in patients with post-thrombotic syndrome;Hohe pravalenz der APC-resistenz (Faktor-V-Leiden-Mutation) bei patienten mit postthrombotischem syndrom

Hautarzt

Volumn 51, Issue 8, 2000, Pages 590-592

  Gaber, Y ^a   Siemens, H J ^a   Schmeller, W ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NONE

Author keywords

APC resistance; Leg ulcers; Postthrombotic syndrome; Prevalence; Varicosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 5;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MUTATION; POSTTHROMBOSIS SYNDROME; PREVALENCE; RISK FACTOR; ULCEROGENESIS; VARICOSIS; CHRONIC VEIN INSUFFICIENCY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; GENETICS; MIDDLE AGED;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FACTOR V; FEMALE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; MUTATION; POSTPHLEBITIC SYNDROME;

EID: 0033623306     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050051176     Document Type: Article

References (21)

1. Thromboserisiko bei oralen Kontrazeptiva: Stellenwerteines Thrombophilie-Screenings
2. Mutation in blood coagulation factor V associated with resistance to activated protein C
3. Resistance to activated protein C and factor V leiden as risk factors for venous thrombosis
4. Inherited thrombophilia: Resistance to activated protein C as a pathogenetic factor of venous thromboembolism
5. Die Venenthrombose
6. Oberflachliche Venenthrombose der unteren Extremitaten: Bedeutung von Faktor V Leiden, Faktor II G20210A und Ubergewicht
7. The risk of recurrent thromboembolism in patients with and without factor V leiden
8. Spatfolgen der tiefen Venenthrombose: Ein 13-Jahres Follow-up von 223 Patienten
9. Activated protein C resitance: Molecular mechanisms
10. Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers
11. Management of venous leg ulcers
12. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: Prevalence of factor V leiden
13. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study
14. The prevalence of factor V leiden mutation in patients with leg ulcers and chronic venous insufficiency
15. Resistance to activated protein C: A common deficiency in patients with venous leg ulceration
16. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in female homozygous for factor V leiden
17. Protein-C-Defekte und andere Ursachen yon Ulcera crurum
18. 506- Gln Mutation in the gene for factor V (factor V leiden)
19. Resistance to activated protein C as a basis for venous thrombosis
20. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls
21. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation